Product Information
BENZONATATE 100 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0656 per EA under NDC 67877057305. Its NADAC has been published 465 times since Nov 8, 2017.
FDA first approved this application on Mar 30, 2007. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877057305
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENZONATATEApproval Type
Generic (ANDA)
FDA Application
ANDA040627FDA Approved
3/30/2007
TE Code
AA
On Market Since
3/22/2017
Pharmacological Classes
Price Statistics
The NADAC for BENZONATATE 100 MG CAPSULE has been published 465 times since Nov 8, 2017, and over the history we have for it it has declined 63.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0656 per EA |
|---|---|
| All-time high | $0.1805 (Nov 15, 2017) |
| All-time low | $0.0522 (Nov 20, 2024) |
| 52-week high | $0.0732 |
| 52-week low | $0.0656 |
| Median price | $0.0898 |
| Average price | $0.0964 |
| Largest weekly change | -31.1% (Nov 20, 2024) |
| Weeks tracked | 465 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BENZONATATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-narcotic Antitussive class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENZONATATE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BENZONATATE 100 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0656 per EA (NDC 67877057305), effective Sep 30, 2026.
How has the price of BENZONATATE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BENZONATATE 100 MG CAPSULE has declined 63.7%. It has been tracked across 465 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for BENZONATATE 100 MG CAPSULE?
Since Nov 8, 2017, the NADAC for BENZONATATE 100 MG CAPSULE has ranged from a low of $0.0522 (Nov 20, 2024) to a high of $0.1805 (Nov 15, 2017), with a median of $0.0898 per EA.
Are there cheaper alternatives to BENZONATATE 100 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BENZONATATE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BENZONATATE 100 MG CAPSULE?
BENZONATATE 100 MG CAPSULE (NDC 67877057305) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.